Bothell-based biopharmaceutical company Athira Pharma Inc. (Nasdaq: ATHA) is paying a $4.1 million fine due to allegations it ...
Seattle-area biotech company Athira Pharma agreed to pay $4.07 million to settle allegations that it violated the False ...
Athira Pharma (ATHA) agreed to pay $4,068,698 to resolve allegations that it violated the False Claims Act by failing to report allegations of ...
U.S. pharmaceutical company pays $4.07 million to resolve allegations that it violated the False Claims Act (FCA) by failing to report research misconduct allegations in grant applications.
Athira Pharma has agreed to pay over $4 million to settle the government's claims that it failed to report alleged research misconduct to federal agencies.
A biopharmaceutical company, Athira Pharma, settled for $4.068 million over allegations of research misconduct.
CEO Mark James Litton sold 25,107 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $0.56, for a total transaction of $14,059.92. Following the ...
A pharmaceutical company in Bothell has agreed to pay $4,068,698 to settle allegations it used falsified research to obtain ...
Stressing the importance of integrity in taxpayer-funded biomedical research, the U.S. Department of Justice reported that Athira Pharma Inc. agreed to pay more than $4 million to resolve False Claims ...
Robert Renninger, the Vice President of Finance at Athira Pharma, Inc. (NASDAQ:ATHA), recently executed several transactions involving the company's stock, according to a filing with the ...
Florida physician Stephen Andrew Leedy, MD, has been accused of producing child sexual abuse materials and enticing minors to ...